Scientific evidence to support a vitamin E and heart disease health claim: Research needs

Journal of Nutrition

Volumn 135, Issue 2, 2005, Pages 348-353

  Jialal, I ^a   Devaraj, S ^a  

^a NONE

Author keywords

Antioxidant; Cardiovascular disease; Clinical trials; Vitamin E; tocopherol

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG POTENCY; HEART DISEASE; HUMAN; LIPID PEROXIDATION; RESEARCH; THROMBOCYTE AGGREGATION; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

EID: 13244255227     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/135.2.348     Document Type: Conference Paper

References (24)

1. Harris, A., Devaraj, S. & Jialal, I. (2002) Oxidative stress, alpha-tocopherol therapy, and atherosclerosis. Curr. Atheroscler. Rep. 4: 373-380.
2. Devaraj, S. & Jialal, I. (1998) The effects of alpha-tocopherol on critical cells in atherogenesis. Curr. Opin. Lipidol. 9: 11-15.
3. Stephens, N. G., Parsons, A., Schofield, P. M., Kelly, F., Cheeseman, K. & Mitchinson, M. J. (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347: 781-786.
4. Yusuf, S., Dagenais, G., Pogue, J., Bosch, J. & Sleight, P. (2000) Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 342: 154-160.
5. Jialal, I. & Devaraj, S. (2002) Prospective vitamin E clinical trials. In: Antioxidant Vitamins C and E (Packer, L., Traber, M., Kraemer, K. & Frei, B., eds.), pp. 243-254. AOCS Press, Champaign, IL.
6. Kaul, N., Devaraj, S. & Jialal, I. (2001) Alpha-tocopherol and atherosclerosis. Exp. Biol. Med. 226: 5-12.
7. Jialal, I. & Devaraj, S. (2003) Antioxidants and atherosclerosis: don't throw out the baby with the bathwater. Circulation 107: 926-928.
8. Boaz, M., Smetana, S., Weinstein, T., Matas, Z., Gafter, U., Iaina, A., Knecht, A., Weissgarten, Y., Brunner, D., Fainaru, M. & Green, M. S. (2000) Secondary prevention with antioxidants of cardiovascular disease in end-stage renal disease (SPACE): randomized placebo controlled trial. Lancet 356: 1213-1218.
9. Mathur, S., Devaraj, S. & Jialal, I. (2002) Accelerated atherosclerosis, dyslipidemia, and oxidative stress in end-stage renal disease. Curr. Opin. Nephrol. Hypertens. 11: 141-147.
10. Hodis, H., Mack, W. & LaBree, L., Mahrer, P. R., Sevanian, A., Liu, C. R., Liu, C. H., Hwang, J., Selzer, R. H., Azen, S. P.; VEAPS Research Group (2002) Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis. Circulation. 106: 1453-1459.
11. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and beta- carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330: 1029-1035.
12. Rapola, J. M., Virtamo, J., Haukka, J. K., Heinonen, O. P., Albanes, D., Taylor, P. R. & Huttunen, J. K. (1996) Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial [see comments]. J. Am. Med. Assoc. 275: 693-698.
13. Steiner, M., Glantz, M. & Lekos, A. (1995) Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks. Am. J. Clin. Nutr. 62: 1381S-1384S.
14. Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., Schneider, L. S. & Thal, L. J. (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N. Engl. J. Med. 336: 1216-1222.
15. Freedman, J. E., Farhat, J. H., Loscalzo, J. & Keaney, J. F. (1996) Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C dependent mechanism. Circulation 94: 2434-2440.
16. GISSI-Prevenzione Investigators (1997) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354: 447-455.
17. Collaborative Group of the Primary Prevention Project (PPP) (2001) Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomized trial in general practice. Lancet 357: 89-95.
18. Salonen, J. T., Nyyssonen, K., Salonen, R., Lakka, H. M., Kaikkonen, J., Porkkala-Sarataho, E., Voutilainen, S., Lakka, T. A., Rissanen, T., Leskinen, L., Tuomainen, T. P., Valkonen, V. P., Ristonmaa, U. & Poulsen, H. E. (2000) Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J. Intern. Med. 248: 377-386.
19. Salonen, R. M., Nyyssonen, K., Kaikkonen, J., Porkkala-Sarataho, E., Voutilainen, S., Rissanen, T. H., Tuomainen, T. P., Valkonen, V. P., Ristonmaa, U., Lakka, H. M., Vanharanta, M., Salonen, J. T. & Poulsen, H. E. (2003) Antioxidant Supplementation in Atherosclerosis Prevention Study. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 107: 947-953.
20. Brown, B. G., Zhau, X. Q., Chait, A., Fisher, L. D., Cheung, M. C., Morse, J. S., Dowdy, A. A., Marino, E. K., Bolson, E. L., Alaupovic, P., Frohlich, J., Serafini, L., Huss-Frechette E., Wang, S., DeAngelis, D., Dodek, A. & Albers, J. J. (2001) Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N. Engl. J. Med. 345: 1583-1592.
21. Fang, J., Kinlay, S., Beltrame, J., Hikiti, H., Wainstein, M., Behrendt, D., Sun, J., Frei, B., Mudge, G. H., Selwyn, A. P. & Ganz, P. (2002) Effect of Vitamins C and E on progression of transplant-associated arteriosclerosis: a randomized trial. Lancet. 359: 1108-1113.
22. Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360: 7-22.
23. Waters, D. D., Alderman, E. L., Hsia, J., Howard, B. V., Cobb, F. R., Rogers, W. J., Ouyang, P., Thompson, P., Tardif, J. C., Higginson, L., Bittner, V., Steffes, M., Gordon, D. J., Proschan, M., Younes, N. & Verter, J. I. (2002) Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. J. Am. Med. Assoc. 288: 2432-2440.
24. Vega-Lopez, S., Kaul, N., Devaraj, S., Cai, R.Y., German, B. & Jialal, I. (2004) Supplementation with omega3 polyunsaturated fatty acids and all-rac α-tocopherol alone and in combination failed to exert an anti-inflammatory effect in human volunteers. Metabolism 53: 236-240.